Skip to content
ARION
Resources

EDC Software Comparison: How to Evaluate a Platform in 2026

The dimensions that actually matter when comparing EDC platforms — study build speed, data quality workflow, SDV, analytics and change control.

Most EDC comparisons turn into a feature checklist — does it have eConsent, does it have randomization, does it support offline mode. Checklists are easy to fill and hard to act on, because two platforms can both check the "has SDV" box and feel completely different to use every single day for the two years a study runs.

A more useful comparison asks how a platform behaves under the conditions every study eventually hits: a protocol amendment mid-study, a site that enters a value nobody's sure about, a monitor who needs to verify three hundred fields by Friday. The dimensions below are the ones that predict that day-to-day friction, in roughly the order they'll matter to you.

Study build speed

How long from protocol PDF to a working eCRF? Some platforms are genuinely no-code and fast to configure; others are flexible but assume a build service or a trained study-design specialist. Neither is wrong, but they imply very different timelines and very different total cost — a fast self-service builder is worth less if your team doesn't have anyone confident using it.

Ask specifically whether the platform can ingest an existing protocol or spreadsheet and propose a structure, versus requiring every field to be defined by hand from a blank builder. That difference alone can be weeks.

Data quality workflow: blocking or not?

This is the one that generates the most site complaints and gets talked about the least in vendor demos. A platform with hard-blocking edit checks stops a coordinator from saving a visit until a flagged value is fixed or overridden — which sounds rigorous, and in practice means the coordinator either fabricates a plausible-looking value to get past the check, or the visit doesn't get recorded on time.

A non-blocking model — where the value saves, gets flagged, and becomes a query for a reviewer to work later — tends to produce cleaner real-world data, because it doesn't create pressure to game the validation. Ask to see what actually happens on screen when a value fails validation, not just whether validation exists.

Source data verification: how granular, and does it inherit?

SDV requirements usually vary by criticality — some fields need 100% verification, some need none, most need a risk-based sample. Ask whether that can be set once at the study level and inherited down to page and field, with overrides only where they're genuinely needed, or whether every field needs its own explicit configuration. The second approach doesn't scale past a small study.

Change control: what happens when the protocol amends?

Every study of meaningful length gets at least one amendment. The question isn't whether the platform allows structural changes after patients are enrolled — most do — it's whether it tells you what you're about to break. A platform that silently drops or retypes a field can quietly orphan existing patient data; one built for this uses a private amendment draft, shows the exact impact (patients, visits, forms, SDV records, signatures affected) before you commit, records the reason for change, and publishes a new version without deleting collected data.

Analytics: is it actually in the platform, or does it export to one?

This is the dimension vendor demos gloss over fastest, because the honest answer for most platforms is "we export to a partner tool or a separate module." That's not automatically wrong, but it means a second system, a second login, and a reconciliation step between what the eCRF says and what the statistician's dataset says.

If native analytics matters to you, ask to see it running against a real dataset in the demo — descriptive stats, a group comparison, a survival curve — not a slide describing that it exists.

Access control: configured, or a setup project?

Role-based access is table stakes everywhere. What varies is whether a platform ships with sensible role definitions already scoped to organization and center, or whether every deployment starts as a bespoke RBAC configuration exercise. For a CRO running many sponsors, or a small team without a dedicated admin, that difference is real setup time.

A short checklist for a vendor demo

A handful of concrete things to ask for, rather than describe:

  • Upload a real protocol page and watch the platform propose a form structure.
  • Enter an out-of-range value and see exactly what happens on screen.
  • Ask to see a structural change applied to a study that already has test patients — does it show impact before committing?
  • Ask to see one real analysis (not a screenshot) run against live study data.
  • Ask who configures roles and centers on day one, and how long that takes.
Questions

FAQ

What is the difference between EDC and CDMS?

EDC (Electronic Data Capture) usually refers to the data-entry layer. A CDMS (Clinical Data Management System) adds review workflows — queries, SDV, cleaning, lock — on top. Some vendors sell them separately; others treat it as one system.

How do most competitor tools compare at scale?

Most established competitor tools have broad product ecosystems and are designed to support large multi-region trials. That scale often comes with a larger, more modular product to configure and a workflow built around exporting to a separate analytics layer.

Do I need decentralized trial (DCT) support?

If any part of your protocol involves patient-reported outcomes captured outside a site visit — symptom diaries, quality-of-life scales, remote follow-up — you need an eCOA/ePRO capability, whether built into the EDC or a separate connected module.

How long does a typical EDC implementation take?

It depends far more on protocol complexity and internal review cycles than on the platform itself. AI-assisted build tools can produce a first-draft structure in minutes, but that's rarely the bottleneck — sponsor and site review usually is.

Is a full-featured EDC overkill for a small academic study?

Not if the platform doesn't require a dedicated data-management function to operate. The workflow that protects a 500-patient multi-center trial — audit trail, role-based access, non-blocking validation — is the same workflow a 20-patient investigator-led study benefits from; the question is whether the platform assumes you have staff to run it.

See it on your protocol

Bring a protocol or an existing study and we'll show you what this looks like in Arion.

Request a demo